TripSitter Clinic Ltd AI Stock Analysis
TripSitter Clinic Ltd (UY00) AI Stock Analysis
TripSitter Clinic Ltd
(Frankfurt:UY00)
No summary available
TripSitter Clinic Ltd (UY00) vs. iShares MSCI Germany ETF (EWG)
- Market Cap
- EUR 1.27M
- Dividend Yield
- ―
- Average Volume (3M)
- ―
- Price to Earnings (P/E)
- -29.7
- Beta (1Y)
- 1.09
- Revenue Growth
- ―
- EPS Growth
- ―
- Country
- Germany
- Employees
- 0
- Sector
- Healthcare
- Sector Strength
- 51
- Industry
- Medical - Care Facilities
TripSitter Clinic Ltd Business Overview & Revenue Model
Company Description
TripSitter Clinic Ltd. operates a consultative virtual clinic and tele-health platform that connects patients to a licensed physician who can evaluate for a prescribed treatment program of low-dose oral ketamine medication in the United States. Its p...
TripSitter Clinic Ltd Peers Comparison
Overall Rating
TSE:VHI69Neutral
TSE:CHS42.4Neutral
TSE:UDOC41Neutral
TSE:AIDR38Underperform
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 69Neutral | CAD 443.90M | 40.16 | 4.03% | ― | 29.32% | 231.82% | |
| Sector * | 51Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% |
| 42Neutral | CAD 10.15M | -1.47 | 64.52% | ― | 7.63% | -106.03% | |
| 41Neutral | CAD 4.32M | -1.33 | 355.56% | ― | 614.03% | 51.97% | |
| 38Underperform | CAD 44.05M | -1.62 | -444.52% | ― | 415.06% | -54.80% |
* Healthcare Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| DE:UY00 | TripSitter Clinic Ltd | 0.09 | 0.06 | 200.00% | |
| TSE:VHI | Vitalhub Corp. | 7.00 | -1.85 | -20.90% | |
| TSE:AIDR | Rocket Doctor Ai Inc | 0.43 | -0.40 | -48.21% | |
| TSE:CHS | Comprehensive Healthcare Systems Inc | 0.35 | -0.17 | -32.69% | |
| TSE:UDOC | Unidoc Health Corp. | 0.05 | -0.15 | -75.00% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
